Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
about
Disparities in Gynecological MalignanciesRole of aggressive surgical cytoreduction in advanced ovarian cancerPractical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumorsEvaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.Spatial analysis of advanced-stage ovarian cancer mortality in California.Using big data for quality assessment in oncology.Perspectives of quality care in cancer treatment: a review of the literature.Ten Important Considerations for Ovarian Cancer ScreeningSurvival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian CancerImpact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings.Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?Cross-sectional study on comorbidities and adverse events in patients with advanced and recurrent ovarian cancer in France.Is It Time to Centralize Ovarian Cancer Care in the United States?Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer.Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.Complications from Surgeries Related to Ovarian Cancer Screening.Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.The clinical utility of an elevated-risk multivariate index assay score in ovarian cancer patients.Molecular targeted therapy in gynaecologic malignancies: primer for radiologists.Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study.Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care.The relationship between psychosocial factors in the patient-oncologist relationship and quality of care: A study of breast cancer patients.Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study.Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women.Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer.Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer.A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.Apical support at the time of hysterectomy for uterovaginal prolapse.Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma.Saudi lung cancer management guidelines 2017.Standardising analgesic administration for nurses: a prospective intervention study.A systematic approach to adnexal masses discovered on ultrasound: the ADNEx MR scoring system.Gynecologic oncologists involvement on ovarian cancer standard of care receipt and survival.Patient, physician, and caregiver perspectives on ovarian cancer treatment decision making: lessons from a qualitative pilot study.
P2860
Q26768263-A4B62E1E-C934-47BB-AC42-41B2FD85087FQ26801358-352F38BA-4A67-4B58-B8EE-2D9B3A21A7D9Q30414045-D651C6AC-4D37-43D2-A0E5-B0AE3914015BQ30428244-95F30256-B4CE-469B-BEC7-E83A4BCEE39CQ30583547-375660A7-8A70-4558-840C-5CE4E3544F99Q30656065-4D453A99-FD8C-4B49-B73F-68DC57F3CC08Q31080159-CD3DD917-973B-4CA6-BF71-45A859E2834CQ33652863-B17CEA9F-1637-4AA2-8901-0E0BD5FF0BECQ33850463-E4BCF37D-FC3B-425E-ADE6-2D028DB0EFA7Q34196183-ECD2203F-6699-4AA7-826E-086C4E17CDC1Q34470171-51B95457-A729-46DD-A649-96F48359D0CCQ34996986-BB358C2D-BFEE-465E-8201-8FD9FFE31A3CQ35206264-79D182E0-89C4-49FD-A32E-EC442A93E1AFQ36239919-6230A95C-AE94-4446-B41E-A16573946226Q36794300-5A70FD58-77E2-450D-912E-ADBA34B15EA0Q36932557-90520CF3-4DF5-44B9-B270-45CBC2937552Q37486444-DD5B967D-5326-48B3-9787-E41D7DD9B23BQ37486453-AA4998CC-C371-4E36-A31A-A356F8E128ADQ37515856-5AEC0301-7153-4863-A26A-75B57691FC4FQ37729985-17A8E51E-0FF9-413E-93E4-EA4D7549FDC8Q38609944-6007B418-7FDC-4EA7-B639-0B61628F5C5EQ38796136-ABC1E751-2681-4517-BA16-45F855DE740FQ38800078-F5719B73-CCC8-43D3-AA52-4052D1D06232Q38849896-A471B6F5-D185-4D1F-8758-B7C4630EED43Q38857898-9ED0AAA7-AC87-433B-815B-49B69672550FQ38861915-CAC04EDC-BEB4-480D-8651-6B58298F71E8Q38861948-2764EBD1-1E0F-44A1-8F31-DFD75FBEB53BQ39130009-2DD2374E-A15A-4216-B6DF-3510D5412E81Q39534429-A0F183AA-75EA-4484-B87E-A53D0DA30E64Q39808566-ED8FDD9F-541F-4B4D-90AB-CEA8BE58FC48Q40087667-4E254B31-5DEB-4820-ABB6-3105F8037CD4Q40186012-E50C4DCD-1777-42D7-995C-2AE15D8A3191Q40331453-183E40BF-EBA7-475E-843A-B9733D4A30CCQ44417388-9B39BDC1-7AE7-456E-B134-817F7776DA9EQ46330226-DB6796CA-F807-4BCA-BFC0-16521480A6D1Q47096145-1098C2A8-963F-4820-AADB-F38467A41CF7Q47680860-E17AE4D0-C101-4105-8677-402D18CD9B29Q50125499-A1D0AAFA-1120-400D-8F17-9DA2E8564097Q55137369-73374D94-08D4-479C-850C-0D813E7033EFQ55668508-CB9DED69-DA30-40EC-A53E-6BFFA0331B04
P2860
Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
@en
Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
@nl
type
label
Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
@en
Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
@nl
prefLabel
Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
@en
Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
@nl
P1476
Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
@en
P2093
Jenny Chang
Robert E Bristow
P304
P356
10.1097/AOG.0B013E3182922A17
P407
P577
2013-06-01T00:00:00Z